List of Tables
Summary Table A: Global Market for Diabetes Treatment, Through 2024
Summary Table B: Global Market for Diabetes Treatment, by Region, Through 2024
Summary Table C: Global Market Shares of Diabetes Treatment, by Region, 2019
Summary Table D: Global Market for Diabetes Treatment, by Product Segment/Subsegment, Through 2024
Table 1: Key Facts and Latest Data for Diabetes Globally, 2017 and 2045
Table 2: IDF Regions Ranked by Prevalence of Diabetes Population Aged 20-79 Years per Region, 2017 and 2045
Table 3: Key Facts and Latest Data for Diabetes Across the North American and Caribbean Regions, 2017 and 2045
Table 4: Key Facts and Latest Data for Diabetes in Europe, 2017 and 2045
Table 5: Key Facts and Latest Data for Diabetes in South and Central America, 2017 and 2045
Table 6: Key Facts and Latest Data for Diabetes in Southeast Asia, 2017 and 2045
Table 7: Key Facts and Latest Data for Diabetes in Western Pacific, 2017 and 2045
Table 8: Key Facts and Latest Data for Diabetes in the Middle East and North Africa, 2017 and 2045
Table 9: Key Facts and Latest Data for Diabetes in Africa, 2017 and 2045
Table 10: Top 10 Countries/Territories with People Aged 20-79 Years Living with Diabetes, 2017 and 2045
Table 11: People Aged 20-79 Years Living with Undiagnosed Diabetes by Region, 2017
Table 12: Top 10 Countries with People Aged 20-79 Years Living with Undiagnosed Diabetes, 2017
Table 13: Ranking of Top 10 Countries Based on Total Healthcare Expenditures on People Aged 20-79 Years with Diabetes, 2017
Table 14: Leading Blood Glucose Manufacturers and Blood Glucose Products
Table 15: Leading Lancet and Lancet Device Manufacturers and Products
Table 16: Comparison of Abbott Freestyle Blood Glucose Monitoring System Readers
Table 17: Leading Insulin Syringes Manufacturers and Insulin Syringe Products
Table 18: Commercially Available Insulin Injector Pens
Table 19: Leading Insulin Jet Injectors Manufacturers and Products
Table 20: Leading External Insulin Pump Manufacturers and Products
Table 21: Key Features of Current Leading Insulin Pump Systems
Table 22: Comparison of Insulin Action of Leading Insulin Products
Table 23: Comparison of GLP-1 Analogs
Table 24: U.S. Patent Expiry Dates for the World's Top Selling Diabetes Drugs
Table 25: Novo Nordisk's Current R&D Pipeline
Table 26: Eli Lilly and Co.'s Current R&D Pipeline
Table 27: AstraZeneca's Current R&D Pipeline
Table 28: Terminology Used to Describe Generic Biopharmaceuticals, by Country/Region
Table 29: Global Market for Diabetes Treatment Technologies, Through 2024
Table 30: Global Market for Diabetes Treatment, by Product Segment/Subsegment, Through 2024
Table 31: Global Market Shares of Diabetes Treatment Technologies, by Product Segment/Subsegment, 2019
Table 32: Global Market Shares of Diabetes Treatment Technologies, by Region, 2019
Table 33: Global Market for Diabetes Treatment, by Region, Through 2024
Table 34: North American Market for Diabetes Treatment, by Product Segment, Through 2024
Table 35: European Market for Diabetes Treatment, by Product Segment, Through 2024
Table 36: Asia-Pacific Market for Diabetes Treatment, by Product Segment, Through 2024
Table 37: Latin American Market for Diabetes Treatment, by Product Segment, Through 2024
Table 38: Middle Eastern and African Market for Diabetes Treatment, by Product Segment, Through 2024
Table 39: Global Market for Glucose Monitoring and Diagnostic Products, Through 2024
Table 40: Global Market for Glucose Monitoring and Diagnostic Products, by Product Subsegment, Through 2024
Table 41: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Product Subsegment, 2019
Table 42: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Region, 2019
Table 43: Global Market for Glucose Monitoring and Diagnostic Products, by Region, Through 2024
Table 44: North American Market for Glucose Monitoring and Diagnostic Products, by Country, Through 2024
Table 45: European Market for Glucose Monitoring and Diagnostics Products, by Country, Through 2024
Table 46: Asia-Pacific Market for Glucose Monitoring and Diagnostic Products, by Country, Through 2024
Table 47: Latin American Market for Glucose Monitoring and Diagnostic Products, by Country, Through 2024
Table 48: Middle Eastern and African Market for Glucose Monitoring and Diagnostic Products, by Country/Region, Through 2024
Table 49: Global Company Market Shares of Glucose Monitoring and Diagnostic Products, 2019
Table 50: Global Market Shares of Blood Glucose Test Strips, Glucose Meters, Lancets and Lancet Devices, by Company, 2019
Table 51: Global Company Market Shares of Continuous Glucose Monitoring Products, 2019
Table 52: Global Market for Insulin Delivery Products and Devices, Through 2024
Table 53: Global Market for Insulin Delivery Products and Devices, by Type, Through 2024
Table 54: Global Market Shares of Insulin Delivery Products and Devices, by Type, 2019
Table 55: Global Market Shares of Insulin Delivery Products and Devices, by Region, 2019
Table 56: Global Market for Insulin Delivery Products and Devices, by Region, Through 2024
Table 57: North American Market for Insulin Delivery Products and Devices, by Country, Through 2024
Table 58: European Market for Insulin Delivery Products and Devices, by Country, Through 2024
Table 59: Asia-Pacific Market for Insulin Delivery Products and Devices, by Country, Through 2024
Table 60: Latin American Market for Insulin Delivery Products and Devices, by Country, Through 2024
Table 61: Middle Eastern and African Market for Insulin Delivery Products and Devices, by Country/Region, Through 2024
Table 62: Global Company Market Shares of Insulin Delivery Products and Devices, 2019
Table 63: Global Market for Diabetic Pharmaceuticals, Through 2024
Table 64: Global Market for Diabetic Pharmaceuticals, by Product Type, Through 2024
Table 65: Global Market Shares of Diabetic Pharmaceuticals, by Product Type, 2019
Table 66: Global Revenues of Leading Antidiabetic Pharmaceutical Companies, 2016-2018
Table 67: Global Market Shares of Diabetic Pharmaceuticals, by Region, 2019
Table 68: Global Market for Diabetic Pharmaceuticals, by Region, Through 2024
Table 69: North American Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
Table 70: European Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
Table 71: Major Chinese Pharmaceutical Companies Developing Antidiabetic Medicines, by Type
Table 72: Asia-Pacific Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
Table 73: Latin American Market for Antidiabetic Pharmaceuticals, by Country, Through 2024
Table 74: Middle Eastern and African Market for Antidiabetic Pharmaceuticals, by Country/Region, Through 2024
Table 75: Global Market Shares of Antidiabetic Pharmaceutical Companies, 2019
Table 76: Abbott Laboratories Revenue, by Business Segment, 2016-2018
Table 77: AstraZeneca PLC Revenue, by Business Segment, 2016-2018
Table 78: AstraZeneca PLC Revenue, by Individual Product, 2018
Table 79: Becton Dickinson Revenue, by Business Segment, 2016-2018
Table 80: Danaher Corp. Revenue, by Business Segment, 2016-2018
Table 81: Boston Scientific Corp. Revenue, by Product Segment, 2016-2018
Table 82: Boston Scientific Corp. Recent Developments, August 2018-May 2019
Table 83: B. Braun Melsungen AG Revenue, by Product Segment, 2016-2018
Table 84: Eli Lilly and Co. Revenue, by Product Segment, 2016-2018
Table 85: GlaxoSmithKline PLC Revenue, by Product Segment, 2016-2018
Table 86: Insulet Corp. Revenue, by Product Segment, 2016-2018
Table 87: Johnson & Johnson Revenue, by Product Segment, 2016-2018
Table 88: Medtronic Inc. Revenue, by Product Segment, 2017-2019
Table 89: Medtronic Inc. Recent Developments, June 2014-May 2019
Table 90: Novo Nordisk A/S Revenue, by Product Segment, 2016-2018
Table 91: Novo Nordisk A/S Revenue, Diabetes and Obesity, 2016-2018
Table 92: Novo Nordisk A/S Revenue, Biopharmaceuticals, 2016-2018
Table 93: Novo Nordisk A/S: Product Development Portfolio
Table 94: Pfizer Inc. Revenue, by Product Segment, 2016-2018
Table 95: Roche Group Revenue, by Product Segment, 2016-2018
Table 96: Roche Group Revenue, by Diagnostic Segment, 2016-2018
Table 97: Roche Group: Product Development Portfolio (Diagnostics)
Table 98: Sanofi S.A. Revenue, by Product Segment, 2016-2018
Table 99: Sanofi S.A. Diabetes Revenue, by Product Segment, 2016-2018
Table 100: Terumo Corp. Revenue, by Business Division, 2016-March 31, 2018
Table 101: Contact Information for Tier 1 Major Multinational Medical Device Corporations
Table 102: Contact Information for Tier 2 Entrepreneurial Small and Medium-Sized Enterprises
Table 103: Government Regulatory Agencies and Professional Organizations
Table 104: Acronyms and Terms Commonly Used in the Diagnosis, Monitoring and Treatment of Diabetes
List of Figures
Summary Figure A: Global Market Sharehlcs of Diabetes Treatment, by Region, 2019
Summary Figure B: Global Market Shares of Diabetes Treatment, by Product Segment/Subsegment, 2019
Figure 1: Global Number of People Aged 20-79 Years Living with Diabetes, by Region, 2017 and 2045
Figure 2: Expenditure Gap in Diabetes: Total Amount Spent and Amount per Person Spent Across IDF Regions
Figure 3: The Hidden Diabetes Epidemic: Proportion of Early Deaths, Undiagnosed Diabetes and Number of People Living with Diabetes per Region
Figure 4: Administration Route for Insulin Delivery
Figure 5: Schematic of a Closed-loop Artificial Pancreas System
Figure 6: Schematic of the Edmonton Protocol
Figure 7: Product Pipeline Portfolio of Diabetology Ltd.
Figure 8: Classification of Injectable Therapies for Diabetes
Figure 9: Classification of Oral Antidiabetic Drugs (OADs)
Figure 10: Global Initiatives Pertaining to Type 2 Diabetes
Figure 11: Type 2 Diabetes Agents in Clinical Development
Figure 12: Clinical Development Pipeline for Hanmi Pharma Co. Ltd.
Figure 13: Global Market Shares of Diabetes Treatment Technologies, by Product Segment/Subsegment, 2019
Figure 14: Global Market Shares of Diabetes Treatment Technologies, by Product Segment/Subsegment, 2019
Figure 15: Global Market Shares of Diabetes Treatment Technologies, by Region, 2019
Figure 16: North American Market for Diabetes Treatment, by Product Segment, 2018-2024
Figure 17: European Market for Diabetes Treatment, by Product Segment, 2018-2024
Figure 18: Asia-Pacific Market for Diabetes Treatment, by Product Segment, 2018-2024
Figure 19: Latin American Market for Diabetes Treatment, by Product Segment, 2018-2024
Figure 20: Middle Eastern and African Market for Diabetes Treatments, by Product Segment, 2018-2024
Figure 21: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Product Subsegment, 2019
Figure 22: Global Market Shares of Glucose Monitoring and Diagnostic Products, by Region, 2019
Figure 23: North American Market Shares of Glucose Monitoring and Diagnostic Products, by Country, 2019
Figure 24: European Market Shares of Glucose Monitoring and Diagnostic Products, by Country, 2019
Figure 25: Key Components of the German Statutory Health Insurance System, 2017
Figure 26: Evolution of Statutory Health Insurance Suppliers in Europe, 1970-2018
Figure 27: Asia-Pacific Market Shares of Glucose Monitoring and Diagnostic Products, by Country, 2019
Figure 28: Latin American Market Shares of Glucose Monitoring and Diagnostics Products, by Country, 2019
Figure 29: Middle Eastern and African Market Shares of Glucose Monitoring and Diagnostic Products, by Country/Region, 2019
Figure 30: Global Company Market Shares of Glucose Monitoring and Diagnostic Products, 2019
Figure 31: Global Company Market Shares of Blood Glucose Test Strips, Glucose Meters, Lancets and Lancet Devices, by Company,2019
Figure 32: Global Company Market Shares of Continuous Glucose Monitoring Products, 2019
Figure 33: Global Market Shares of Insulin Delivery Products and Devices, by Type, 2019
Figure 34: Global Market Shares of Insulin Delivery Products and Devices, by Region, 2019
Figure 35: North American Market Shares of Insulin Delivery Products and Devices, by Country, 2019
Figure 36: European Market Shares of Insulin Delivery Products and Devices, by Country, 2019
Figure 37: Asia-Pacific Market Shares of Insulin Delivery Products and Devices, by Country, 2019
Figure 38: Latin American Market Shares of Insulin Delivery Products and Devices, by Country, 2019
Figure 39: The Middle East and African Market Shares of Insulin Delivery Products and Devices, by Country/Region, 2019
Figure 40: Global Company Market Shares of Insulin Delivery Products and Devices, 2019
Figure 41: Global Market Shares of Diabetic Pharmaceuticals, by Product Type, 2019
Figure 42: Evolution of the Top Selling Diabetes Drugs Globally, 2010-2018
Figure 43: Global Market Shares of Diabetic Pharmaceuticals, by Region, 2019
Figure 44: North American Market for Antidiabetic Pharmaceuticals, by Country, 2019
Figure 45: European Market Shares of Antidiabetic Pharmaceuticals, by Country, 2019
Figure 46: Asia-Pacific Market Shares of Antidiabetic Pharmaceuticals, by Country, 2019
Figure 47: Latin American Market Shares of Antidiabetic Pharmaceuticals, by Country, 2019
Figure 48: Middle Eastern and African Market Shares of Antidiabetic Pharmaceuticals, by Country/Region, 2019
Figure 49: Global Market Shares of Antidiabetic Pharmaceutical Companies, 2019
